Sep 30, 2026 04:16AM
Jul 17, 2026 05:11AM
Feb 2, 2026 06:29AM
Dec 18, 2025 06:47AM
Dec 17, 2025 04:32AM
Dec 15, 2025 06:41AM
Nov 11, 2025 11:50PM DBV Technologies completes last patient visit in peanut patch trial
Nov 11, 2025 11:50PM
Sep 16, 2025 04:10AM
May 27, 2025 04:13AM
Apr 23, 2025 04:19AM
Mar 27, 2025 10:30PM
Mar 24, 2025 02:30AM
Jan 8, 2025 04:06PM DBV Technologies (DBVT) Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
Oct 24, 2024 06:42AM
May 8, 2024 06:52AM
Apr 19, 2023 05:10PM
Apr 19, 2023 05:09PM
Mar 7, 2023 04:35PM
Mar 7, 2023 04:30PM
Dec 23, 2022 04:58AM DBV Technologies (DBVT) Announces FDA Lifted Partial Clinical Hold on VITESSE Phase 3 Trial
Dec 23, 2022 01:30AM
Nov 9, 2022 01:30AM
Nov 3, 2022 04:30PM
Sep 21, 2022 06:06PM
Sep 21, 2022 05:47PM
Sep 21, 2022 05:45PM
Sep 7, 2022 04:30PM DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7 Years
Aug 10, 2022 04:50PM
Aug 1, 2022 04:30PM
Jun 28, 2022 06:15PM
Jun 8, 2022 09:19AM
Jun 7, 2022 06:00PM
Jun 7, 2022 04:30PM
Jun 7, 2022 04:30PM DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers
May 2, 2022 04:00PM
Mar 3, 2022 04:15PM
Dec 20, 2021 04:16PM
Dec 20, 2021 04:15PM
Oct 26, 2021 04:15PM
Aug 2, 2021 04:15PM
May 3, 2021 09:07AM DBV Technologies S.A (DBVT) PT Lowered to $6 at Stifel
Mar 11, 2021 04:30PM
Feb 22, 2021 01:30AM
Jan 15, 2021 09:22AM
Jan 15, 2021 07:43AM
Jan 14, 2021 05:31PM
Jan 14, 2021 04:31PM
Jan 14, 2021 04:30PM DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years
Nov 2, 2020 08:41AM

333,294 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All